Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.540
-0.020 (-0.56%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Molecular Partners AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Molecular Partners AG stock has a target of 4.00, which predicts a 12.99% increase from the current stock price of 3.54.
Price Target: $4.00 (+12.99%)
Analyst Consensus: Hold
* Price targets were last updated on Sep 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Molecular Partners AG is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $4.5 → $4 | Hold | Maintains | $4.5 → $4 | +12.99% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | +27.12% | Dec 5, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $30 → $8 | Buy → Hold | Downgrades | $30 → $8 | +125.99% | Aug 29, 2022 |
| Credit Suisse | Credit Suisse | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | May 25, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $29 | Buy | Maintains | $42 → $29 | +719.21% | Apr 27, 2022 |
Financial Forecast
Revenue This Year
1.02M
from 4.97M
Decreased by -79.48%
Revenue Next Year
11.22M
from 1.02M
Increased by 1,000.00%
EPS This Year
-1.52
from -1.59
EPS Next Year
-1.27
from -1.52
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1M | 23.1M | |||
| Avg | 1.0M | 11.2M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -57.7% | 2,164.7% | |||
| Avg | -79.5% | 1,000.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.45 | -0.62 | |||
| Avg | -1.52 | -1.27 | |||
| Low | -1.57 | -1.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.